<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="tab2" orientation="portrait" position="float">
 <label>Table 2</label>
 <caption>
  <p>Top priority emerging infectious diseases.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="left" rowspan="1" colspan="1">Emerging disease</th>
    <th align="left" rowspan="1" colspan="1">Crimean-Congo haemorrhagic fever</th>
    <th align="left" rowspan="1" colspan="1">Ebola virus disease &amp; Marburg haemorrhagic fever</th>
    <th align="left" rowspan="1" colspan="1">Middle East Respiratory Syndrome &amp; SARS</th>
    <th align="left" rowspan="1" colspan="1">Lassa Fever</th>
    <th align="left" rowspan="1" colspan="1">Nipah</th>
    <th align="left" rowspan="1" colspan="1">Rift Valley Fever</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left" rowspan="1" colspan="1">Year of (re)emergence</td>
    <td align="left" rowspan="1" colspan="1">(1) 12th Century,
     <break/>(2) 1944-45 &amp; 1967
    </td>
    <td align="left" rowspan="1" colspan="1">Ebola: 1976
     <break/>Marburg: 1967
    </td>
    <td align="left" rowspan="1" colspan="1">MERS: 2012
     <break/>SARS: 2002
    </td>
    <td align="left" rowspan="1" colspan="1">Isolated in 1969</td>
    <td align="left" rowspan="1" colspan="1">1998-1999</td>
    <td align="left" rowspan="1" colspan="1">In livestock: 1910s
     <break/>In humans: 1931 (all in Kenya)
    </td>
   </tr>
   <tr>
    <td align="center" colspan="7" rowspan="1">
     <hr/>
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Causative organism</td>
    <td align="left" rowspan="1" colspan="1">
     <italic>Nairovirus (CCHF virus)</italic>
    </td>
    <td align="left" rowspan="1" colspan="1">EVD: Ebola virus
     <break/>MHF: Marburg virus
    </td>
    <td align="left" rowspan="1" colspan="1">MERS: MERS-CoV</td>
    <td align="left" rowspan="1" colspan="1">Lassa virus</td>
    <td align="left" rowspan="1" colspan="1">Nipah virus (NiV)</td>
    <td align="left" rowspan="1" colspan="1">Rift Valley Fever (RVF) virus</td>
   </tr>
   <tr>
    <td align="center" colspan="7" rowspan="1">
     <hr/>
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Type/class of organism</td>
    <td align="left" rowspan="1" colspan="1">Virus (
     <italic>Bunyaviridae</italic>)
    </td>
    <td align="left" rowspan="1" colspan="1">Virus (
     <italic>Filoviridae</italic>)
    </td>
    <td align="left" rowspan="1" colspan="1">Virus (Coronaviridae)</td>
    <td align="left" rowspan="1" colspan="1">Virus (Arenaviridae)</td>
    <td align="left" rowspan="1" colspan="1">Virus (Paramyxoviridae)</td>
    <td align="left" rowspan="1" colspan="1">Virus (Bunyaviridae)</td>
   </tr>
   <tr>
    <td align="center" colspan="7" rowspan="1">
     <hr/>
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Vector/animal host</td>
    <td align="left" rowspan="1" colspan="1">
     <italic>Hyalomma</italic> tick,
     <break/>Domestic animals
    </td>
    <td align="left" rowspan="1" colspan="1">Fruit bats species
     <break/>EVD: Pteropodidae
     <break/>MHF: 
     <italic>Rousettus aegypti</italic>
    </td>
    <td align="left" rowspan="1" colspan="1">Not well known; camel is implicated as reservoir host</td>
    <td align="left" rowspan="1" colspan="1">
     <italic>Mastomys</italic> rats
    </td>
    <td align="left" rowspan="1" colspan="1">Fruit bats of genus 
     <italic>Pteropus</italic>
    </td>
    <td align="left" rowspan="1" colspan="1">(1) Mosquito species, mainly 
     <italic>Aedes</italic> sp.
     <break/>(2) Domestic remnant
    </td>
   </tr>
   <tr>
    <td align="center" colspan="7" rowspan="1">
     <hr/>
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Epidemiology</td>
    <td align="left" rowspan="1" colspan="1">Fatality rate of 10–40%, at least 140 outbreaks &amp; &gt;5000 cases since 1967</td>
    <td align="left" rowspan="1" colspan="1">EVD: about 50% fatality. At least 31,076 cases with 12,922 deaths since 1976
     <break/>MHF: case fatality rate is up to 88%
    </td>
    <td align="left" rowspan="1" colspan="1">MERS: case fatality approx. 36%; severe in people with weakened immune systems, with chronic diseases</td>
    <td align="left" rowspan="1" colspan="1">At least 100,000 cases annually in the endemic regions of West Africa with case fatality rates of 5–10%</td>
    <td align="left" rowspan="1" colspan="1">At least 477 people infected, 252 killed since 1998; case fatality rate of 40–70%</td>
    <td align="left" rowspan="1" colspan="1">Commonly affects livestock, causing disease, abortion, and death in thousands of domesticated animals</td>
   </tr>
   <tr>
    <td align="center" colspan="7" rowspan="1">
     <hr/>
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Populations at risk</td>
    <td align="left" rowspan="1" colspan="1">Endemic in Africa, the Balkans, the Middle East, and Asia</td>
    <td align="left" rowspan="1" colspan="1">EBV: Africa
     <break/>MHF: Frankfurt in Germany; Belgrade and Africa
    </td>
    <td align="left" rowspan="1" colspan="1">MERS: people with chronic disease. Countries include Egypt, Oman, Qatar, and Saudi Arabia</td>
    <td align="left" rowspan="1" colspan="1">Endemic in West Africa</td>
    <td align="left" rowspan="1" colspan="1">Southeast Asia region</td>
    <td align="left" rowspan="1" colspan="1">Africa and Arabian Peninsula</td>
   </tr>
   <tr>
    <td align="center" colspan="7" rowspan="1">
     <hr/>
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Mode of transmission</td>
    <td align="left" rowspan="1" colspan="1">(1) Tick bites
     <break/>(2) Zoonotic: contact with infected animal blood and with secretions or body fluids of infected persons
    </td>
    <td align="left" rowspan="1" colspan="1">EBV: contact with blood, secretions, and body fluids/organs of infected (a) nonhuman primates and (b) humans
     <break/>MHF: mainly human-to-human
    </td>
    <td align="left" rowspan="1" colspan="1">MERS is zoonotic: no human-to-human transmission; origin and exact route are unknown</td>
    <td align="left" rowspan="1" colspan="1">Zoonotic: (1) exposure to urine or faeces of infected 
     <italic>Mastomys </italic>rats
     <break/>(2) Direct contact with body fluids of infected person
    </td>
    <td align="left" rowspan="1" colspan="1">(1) Contact with excretion and secretion of infected bats
     <break/>(2) Direct contact with infected pigs
    </td>
    <td align="left" rowspan="1" colspan="1">Zoonotic and Epizootic:
     <break/>Bite of infected mosquitoes (in humans and animals)
    </td>
   </tr>
   <tr>
    <td align="center" colspan="7" rowspan="1">
     <hr/>
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Clinical presentations</td>
    <td align="left" rowspan="1" colspan="1">Nonspecific: high fever, myalgia, headache, nausea, abdominal pain, and nonbloody diarrhoea</td>
    <td align="left" rowspan="1" colspan="1">Clinically similar: fever, severe headache, diarrhoea, lethargy, and so on; impaired kidney function, internal /external bleeding, and nervous system problems (MHF)</td>
    <td align="left" rowspan="1" colspan="1">Ranges from no symptoms to death. Generally fever, cough, and shortness of breath; pneumonia, gastrointestinal problems, and respiratory failure</td>
    <td align="left" rowspan="1" colspan="1">About 80% of infections are asymptomatic. Symptoms are variable: fever, cough, malaise; pains, fluid in the lung cavity, facial swelling, bleeding, and more</td>
    <td align="left" rowspan="1" colspan="1">(1) Barking pig syndrome (in pigs)
     <break/>(2) In humans: fever, muscle pain; brain inflammation leading to coma
    </td>
    <td align="left" rowspan="1" colspan="1">Humans: include fever, muscle/joint pain; eye disease, meningoencephalitis, and haemorrhagic fever
     <break/>Animals: mortality and abortion
    </td>
   </tr>
   <tr>
    <td align="center" colspan="7" rowspan="1">
     <hr/>
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Pathogenesis</td>
    <td align="left" rowspan="1" colspan="1">Not well understood</td>
    <td align="left" rowspan="1" colspan="1">Not well understood</td>
    <td align="left" rowspan="1" colspan="1">Not well understood</td>
    <td align="left" rowspan="1" colspan="1">Not well understood</td>
    <td align="left" rowspan="1" colspan="1">Not well understood</td>
    <td align="left" rowspan="1" colspan="1">Not well understood</td>
   </tr>
   <tr>
    <td align="center" colspan="7" rowspan="1">
     <hr/>
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Diagnosis</td>
    <td align="left" rowspan="1" colspan="1">(1) Virus isolation by cell culture
     <break/>(2) Viral genome detection (RT-PCR)
     <break/>(3) Serology (ELISA)
    </td>
    <td align="left" rowspan="1" colspan="1">(1) Virus isolation by cell culture
     <break/>(2) Viral genome detection (RT-PCR)
     <break/>(3) Serology (e.g., ELISA)
    </td>
    <td align="left" rowspan="1" colspan="1">(1) Mainly by molecular detection (RT-PCR)
     <break/>(2) Also serology (ELISA)
    </td>
    <td align="left" rowspan="1" colspan="1">Only in reference labs: isolation by cell culture, viral genome detection (RT-PCR), and serology (ELISA &amp; neutralization)</td>
    <td align="left" rowspan="1" colspan="1">(1) Virus isolation
     <break/>(2) Histopathology
     <break/>(3) RT-PCR
     <break/>(4) Serology (ELISA, neutralization)
    </td>
    <td align="left" rowspan="1" colspan="1">(1) Isolation by cell culture
     <break/>(2) Viral genome detection (RT-PCR)
     <break/>(3) Serology (ELISA)
    </td>
   </tr>
   <tr>
    <td align="center" colspan="7" rowspan="1">
     <hr/>
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Treatment</td>
    <td align="left" rowspan="1" colspan="1">No vaccine available:
     <break/>(1) General supportive care management
     <break/>(2) Ribavirin antiviral
    </td>
    <td align="left" rowspan="1" colspan="1">No vaccine or specific antiviral treatment. General supportive care management</td>
    <td align="left" rowspan="1" colspan="1">MERS: no vaccine or specific treatment. General supportive care management</td>
    <td align="left" rowspan="1" colspan="1">No vaccine yet
     <break/>(1) Early supportive care
     <break/>(2) Ribavirin antiviral therapy seems effective
    </td>
    <td align="left" rowspan="1" colspan="1">No vaccine available
     <break/>(1) Symptoms management;
     <break/>(2) Ribavirin antiviral treatment
    </td>
    <td align="left" rowspan="1" colspan="1">No specific treatment; generally supportive therapy</td>
   </tr>
   <tr>
    <td align="center" colspan="7" rowspan="1">
     <hr/>
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Prevention</td>
    <td align="left" rowspan="1" colspan="1">Minimize tick burden in livestock, minimize human contact with vertebrate hosts</td>
    <td align="left" rowspan="1" colspan="1">Awareness
     <break/>EVD: good hygiene; avoid contact with blood and body fluids
     <break/>MHF: protect pigs from fruit bats contact
    </td>
    <td align="left" rowspan="1" colspan="1">MERS: general hygiene measures in contacting camels/other animals; avoid consumption of raw or undercooked animal products</td>
    <td align="left" rowspan="1" colspan="1">(1) Good hygiene—in community, homes
     <break/>(2) Standard infection prevention and control measures in healthcare and lab settings
    </td>
    <td align="left" rowspan="1" colspan="1">Avoid contact with infected secretions, excretions, blood, or tissues of infected pigs and bats</td>
    <td align="left" rowspan="1" colspan="1">(1) Animal vaccination
     <break/>(2) Protection against vector bites
     <break/>(3) Animal health surveillance
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>
    <italic>Note</italic>. Source of list: 
    <ext-link ext-link-type="uri" xlink:href="http://www.who.int/medicines/ebola-treatment/WHO-list-of-top-emerging-diseases/en.com" xmlns:xlink="http://www.w3.org/1999/xlink">http://www.who.int/medicines/ebola-treatment/WHO-list-of-top-emerging-diseases/en/</ext-link> [
    <xref rid="B69" ref-type="bibr">9</xref>].
   </p>
  </fn>
  <fn>
   <p>MERS: Middle East Respiratory Syndrome; SARS: Severe Acute Respiratory Syndrome.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
